This is an NIH R01 research grant for teams developing and using molecular imaging methods to study inflammation in cancer in living systems, with a required collaboration between cancer scientists and imaging scientists. It is for research organizations, not companies selling products or services; if you are not doing cancer or imaging research, do not bother applying.
| Industry | Estimated fit |
|---|---|
| Healthcare & BiotechMatches your industry (clinical) | 76 |
| Agriculture & FarmingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Arts & CultureLimit: Nothing in this notice points to arts & culture | 54 |
| Education & TrainingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech | 54 |
| Environment & ConservationLimit: Nothing in this notice points to environment & conservation | 54 |
| Industry | Estimated fit |
|---|---|
| Finance & BankingLimit: Nothing in this notice points to finance & banking | 54 |
| Food & BeverageLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Housing & Real EstateLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| ManufacturingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Retail & E-CommerceLimit: Nothing in this notice points to retail & e-commerce | 54 |
| Social Services & NonprofitLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Technology & SoftwareLimit: Nothing in this notice points to technology & software | 54 |
| Transportation & LogisticsLimit: Nothing in this notice points to transportation & logistics | 50 |
| Construction & InfrastructureLimit: Nothing in this notice points to construction & infrastructure | 49 |
These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.
NIH R01 research grants to develop and use molecular imaging methods to study inflammation in cancer in vivo. Eligible applicants include small businesses, for-profit organizations, nonprofits, universities, state/local/tribal governments, and federal agencies; foreign entities are not eligible. Funds support collaborative research between cancer scientists and imaging scientists.
The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of current imaging research into the role of inflammation in cancer is largely based on in vitro and ex vivo methods with limited utilization of imaging approaches that could lead to significant new insights relevant to dynamic cancer and inflammation interactions. Utilization of molecular imaging probes in pre-clinical and clinical investigations for precise temporal resolution at the molecular and cellular level are valuable approaches for identification and characterization of in vivo inflammatory cellular physiology in cancers and of molecular changes in response to treatment. This FOA encourages applications that focus on developing integrated imaging approaches to interrogate the role of inflammation in cancer through strong cross-field collaboration between cancer basic science researchers and imaging scientists. These collaborations are expected to advance science and understanding of cancer inflammation interactions.
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Topics
Open opportunities funding similar work, from the same funder or in the same place.
NIH BRAIN Initiative grants to develop tools and computational models for high-resolution, synchronous measurement of complex behaviors alongside neural activity in humans and other species. Eligible applicants include…
NIH/NCI K99/R00 career-development award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent tenure-track faculty positions; requires the candidate to lead an…
NIH/NCI UH3 cooperative agreement to clinically validate established molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, or treatment response using specimens from…
NIH/NCI K99/R00 award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent faculty careers. The applicant is typically the sponsoring institution; eligible…
NIH/NCI cooperative agreement (UH2/UH3) funding validation of molecular, cellular, and imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response. Open to universities,…
NIH/NCI program funding revision applications to adapt and clinically validate molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response prediction.…